Literature DB >> 12588343

Guidelines on the diagnosis and management of the thrombotic microangiopathic haemolytic anaemias.

Sarah L Allford1, Beverley J Hunt, Peter Rose, Samuel J Machin.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 12588343     DOI： 10.1046/j.1365-2141.2003.04049.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  71 in total

1.  A case of atypical hemolytic uremic syndrome due to anti-factor H antibody in a patient presenting with a factor XII deficiency identified two novel mutations.

Authors:  Eiji Matsukuma; Yoshimitsu Gotoh; Yoshiyuki Kuroyanagi; Takuji Yamada; Mitsuji Iwasa; Satoshi Yamakawa; Takuhito Nagai; Nobuaki Takagi; Hiromu Mae; Kenji Iijima; Elena Bresin
Journal:  Clin Exp Nephrol       Date:  2011-01-27       Impact factor: 2.801

Review 2.  [Thrombophilic states in intensive care medicine].

Authors:  L Engelmann
Journal:  Med Klin Intensivmed Notfmed       Date:  2011-10-28       Impact factor: 0.840

3.  Rituximab for managing relapsing or refractory patients with idiopathic thrombotic thrombocytopenic purpura--haemolytic uraemic syndrome.

Authors:  Domenica Caramazza; Gerlando Quintini; Ignazio Abbene; Lucio Lo Coco; Alessandra Malato; Rosa Di Trapani; Giorgia Saccullo; Giuseppina Pizzo; Roberto Palazzolo; Rita Barone; Giuseppina Mazzola; Sergio Rizzo; Paolo Ragonese; Paolo Aridon; Vincenzo Abbadessa; Sergio Siragusa
Journal:  Blood Transfus       Date:  2010-07       Impact factor: 3.443

Review 4.  Rituximab provided long-term remission in a patient with refractory relapsing thrombotic thrombocytopenic purpura.

Authors:  Satoru Kosugi; Masanori Matsumoto; Yasushi Ohtani; Hironori Take; Hiromichi Ishizashi; Yoshihiro Fujimura; Jun Kuyama
Journal:  Int J Hematol       Date:  2005-06       Impact factor: 2.490

5.  Intravenous cyclophosphamide therapy in a case with refractory thrombotic microangiopathic hemolytic anemia and SLE.

Authors:  Jun Akaogi; Noriko Akasaka; Hidehiro Yamada; Nobuaki Hama; Minoru Satoh; Cody Nichols; Shoichi Ozaki
Journal:  Clin Rheumatol       Date:  2004-12       Impact factor: 2.980

6.  A dramatic response to rituximab in a patient with resistant thrombotic thrombocytopenic purpura (TTP) who developed acute stroke.

Authors:  Hakan Ozdogu; Can Boga; Ebru Kizilkilic; Mahmut Yeral; Ilknur Kozanoglu; Mehmet Karatas
Journal:  J Thromb Thrombolysis       Date:  2007-01-13       Impact factor: 2.300

Review 7.  Recommendations for the transfusion of plasma and platelets.

Authors:  Giancarlo Liumbruno; Francesco Bennardello; Angela Lattanzio; Pierluigi Piccoli; Gina Rossetti
Journal:  Blood Transfus       Date:  2009-04       Impact factor: 3.443

8.  Recommendations from the Tuscan Transfusion System on the appropriate use of solvent/detergent-inactivated fresh-frozen plasma.

Authors:  Giancarlo Maria Liumbruno; Maria Laura Sodini; Giuliano Grazzini
Journal:  Blood Transfus       Date:  2008-01       Impact factor: 3.443

9.  Thrombotic thrombocytopenic purpura in a new onset lupus patient?

Authors:  Nery Sablón González; Noel Lorenzo; Yanet Parodis; Maria Belen Alonso Ortiz; Melek Kechida; Jose Carlos Rodriguez Perez
Journal:  Immunol Res       Date:  2017-04       Impact factor: 2.829

Review 10.  Osteonecrosis secondary to antiphospholipid syndrome: a case report, review of the literature, and treatment strategy.

Authors:  Waqar Haque; Huseyin Kadikoy; Omar Pacha; Joseph Maliakkal; Vu Hoang; Abdul Abdellatif
Journal:  Rheumatol Int       Date:  2009-12-12       Impact factor: 2.631
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.